Incyte Corp [INCY] stock is trading at $70.81, up 4.83%. An important factor to consider is whether the stock is rising or falling in short-term value. The INCY shares have gain 3.72% over the last week, with a monthly amount glided 8.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on June 16, 2025, when Stifel upgraded its rating to a Buy but kept the price target unchanged to $107 for it. Previously, William Blair downgraded its rating to Mkt Perform on March 18, 2025. On March 18, 2025, downgrade downgraded it’s rating to Neutral. UBS started tracking the stock assigning a Neutral rating and suggested a price target of $77 on December 17, 2024. BofA Securities upgraded its rating to a Buy and raised its price target to $90 on October 29, 2024. Wolfe Research started tracking with a Outperform rating for this stock on October 01, 2024, and assigned it a price target of $84. In a note dated September 18, 2024, Truist downgraded an Hold rating on this stock and revised its target price from $83 to $74.
Incyte Corp [INCY] stock has fluctuated between $53.56 and $83.95 over the past year. Currently, Wall Street analysts expect the stock to reach $79.5 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $70.81 at the most recent close of the market. An investor can expect a potential return of 12.27% based on the average INCY price forecast.
Analyzing the INCY fundamentals
Incyte Corp [NASDAQ:INCY] reported sales of 4.41B for the trailing twelve months, which represents a growth of 19.53%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 69.93 points at the first support level, and at 69.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.59, and for the 2nd resistance point, it is at 72.38.
Ratios To Look Out For
For context, Incyte Corp’s Current Ratio is 2.04. On the other hand, the Quick Ratio is 2.00, and the Cash Ratio is 1.13. Considering the valuation of this stock, the price to sales ratio is 3.11, the price to book ratio is 3.74 and price to earnings (TTM) ratio is 219.09.
Transactions by insiders
Recent insider trading involved Denton Sheila A., EVP & General Counsel, that happened on Jun 03 ’25 when 1795.0 shares were sold. Officer, SHEILA DENTON completed a deal on Jun 03 ’25 to buy 1795.0 shares. Meanwhile, Principal Accounting Officer Tray Thomas sold 963.0 shares on May 30 ’25.
